Roundtable Discussion: Exploring What More Needs to be Done to Develop & Establish Hippo Pathway Biomarkers
Time: 12:45 pm
day: Conference Day One
- How do we find evidence for target/pathway regulation biomarkers?
- Does inhibiting TEAD create a measurable functional effect on disease that could act as a biomarker?
- Are we selecting the right patients with the right TEAD isoform mutations?
- Are there biomarkers of resistance and how do we find them?
- What is the feasibility for clinical biomarker assays?